Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
- PMID: 32774765
- PMCID: PMC7385512
- DOI: 10.4240/wjgs.v12.i6.269
Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) presents high incidence throughout the world and has been progressively increasing in prevalence. This disease has a heterogeneous natural history, including simple steatosis, nonalcoholic steatohepatitis (NASH), and cirrhosis. The factors that determine its evolution to more severe forms of the disease are still poorly understood, and micronutrients with antioxidant potential may be involved in the pathophysiology of the disease.
Aim: To evaluate the relationship between serum levels of micronutrients and the severity of NAFLD.
Methods: A retrospective, observational and cross-sectional study was conducted. This study included all patients undergoing bariatric surgery who experienced liver biopsy during the procedure, and had serum levels of micronutrients (vitamin D, vitamin B12, zinc, iron, and magnesium), which was assessed in a preoperative evaluation conducted at a reference center in southern Brazil.
Results: A total of 614 patients were analyzed, of which 93% had steatosis, 70.7% had NASH, and 49.3% had some degree of fibrosis. Serum levels of vitamin D were negatively correlated with the severity of steatosis and NASH, and serum levels of vitamin B12 were positively correlated with the severity of steatosis and fibrosis. The other micronutrients showed no association with NAFLD staging.
Conclusion: Serum levels of vitamin D are inversely related to the severity of steatosis and NASH, and serum levels of vitamin B12 are higher in more advanced stages of simple steatosis and liver fibrosis. Serum levels of zinc, iron, and magnesium were not associated with NAFLD severity.
Keywords: Iron; Liver cirrhosis; Magnesium; Micronutrients; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Vitamin B12; Vitamin D; Zinc.
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Similar articles
-
Folate and B12 Levels Correlate with Histological Severity in NASH Patients.Nutrients. 2018 Apr 2;10(4):440. doi: 10.3390/nu10040440. Nutrients. 2018. PMID: 29614799 Free PMC article.
-
Serum homocysteine levels in patients with nonalcoholic fatty liver disease.Ann Hepatol. 2012 Jan-Feb;11(1):68-76. Ann Hepatol. 2012. PMID: 22166563
-
A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.J Acad Nutr Diet. 2014 Aug;114(8):1181-94. doi: 10.1016/j.jand.2014.01.009. Epub 2014 Mar 14. J Acad Nutr Diet. 2014. PMID: 24631112
-
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539. World J Gastroenterol. 2014. PMID: 25400438 Free PMC article. Review.
-
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263. World J Gastroenterol. 2017. PMID: 29307986 Free PMC article. Review.
Cited by
-
Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease.Sci Rep. 2024 Jan 11;14(1):1105. doi: 10.1038/s41598-024-51609-3. Sci Rep. 2024. PMID: 38212362 Free PMC article.
-
Bi-directional causal effect between vitamin B12 and non-alcoholic fatty liver disease: Inferring from large population data.Front Nutr. 2023 Mar 6;10:1015046. doi: 10.3389/fnut.2023.1015046. eCollection 2023. Front Nutr. 2023. PMID: 36950332 Free PMC article.
-
Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults.Front Nutr. 2021 Nov 11;8:760985. doi: 10.3389/fnut.2021.760985. eCollection 2021. Front Nutr. 2021. PMID: 34869532 Free PMC article.
-
The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease.Metabol Open. 2021 Jun 29;11:100105. doi: 10.1016/j.metop.2021.100105. eCollection 2021 Sep. Metabol Open. 2021. PMID: 34337376 Free PMC article.
-
Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults.Sci Rep. 2021 May 17;11(1):10387. doi: 10.1038/s41598-021-89991-x. Sci Rep. 2021. PMID: 34002001 Free PMC article.
References
-
- Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002;17 Suppl:S186–S190. - PubMed
-
- Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology. 2002;35:746–752. - PubMed
-
- Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151–171. - PubMed
-
- Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43:617–649. - PubMed
LinkOut - more resources
Full Text Sources
